US2022183296A1PendingUtilityA1

Herbicidal composition and method for controlling weeds

Assignee: SUMITOMO CHEMICAL COPriority: Mar 20, 2019Filed: Jan 16, 2020Published: Jun 16, 2022
Est. expiryMar 20, 2039(~12.6 yrs left)· nominal 20-yr term from priority
Inventors:Yoshinao Sada
A01N 43/54A01N 25/32A01N 43/84A01N 43/82A01N 57/20A01N 43/38
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided is a herbicidal composition comprising a PPO inhibitor and glufosinate or its salt, wherein the weight ratio of the PPO inhibitor to glufosinate or its salt is 1/2,000 or less. The herbicidal composition can effectively control weeds with reduced crop injury.

Claims

exact text as granted — not AI-modified
1 . A herbicidal composition comprising a PPO inhibitor and glufosinate or its salt, wherein the weight ratio of the PPO inhibitor to glufosinate or its salt is 1/2,000 or less. 
     
     
         2 . The herbicidal composition according to  claim 1 , wherein the weight ratio of the PPO inhibitor to glufosinate or its salt is from 1/2,000,000 to 1/2,000. 
     
     
         3 . The herbicidal composition according to  claim 1 , wherein the PPO inhibitor is selected from the group consisting of saflufenacil, trifludimoxazin, flumioxazin, ethyl [3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate, sulfentrazone, lactofen, fomesafen or its salt, flumiclorac-pentyl, carfentrazone-ethyl, fluthiacet-methyl, and tiafenacil. 
     
     
         4 . A method for controlling weeds in a crop field comprising a step of applying a PPO inhibitor and glufosinate or its salt to the weeds or a soil of the place where the weeds are growing or will grow, wherein the weight ratio of the PPO inhibitor to glufosinate or its salt is 1/2,000 or less. 
     
     
         5 . The method according to  claim 4 , wherein the weight ratio of the PPO inhibitor to glufosinate or its salt is from 1/2,000,000 to 1/2,000. 
     
     
         6 . The method according to  claim 4 , wherein the PPO inhibitor is selected from the group consisting of saflufenacil, trifludimoxazin, flumioxazin, ethyl [3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate, sulfentrazone, lactofen, fomesafen or its salt, flumiclorac-pentyl, carfentrazone-ethyl, fluthiacet-methyl, and tiafenacil.

Join the waitlist — get patent alerts

Track US2022183296A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.